跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 160 条关于
“EDSS”
全部
160
临床试验
121
药物
4
机构
0
资讯
35
去年
Simvastatin Fails to Reduce Disability Progression in Phase 3 MS-STAT2 Trial for Secondary Progressive Multiple Sclerosis
3年前
Real-world Evaluation of Ocrelizumab in Multiple Sclerosis Shows Promising Results
11个月前
Vidofludimus Calcium Shows Promise for Progressive MS Despite Missing Primary Endpoint in Phase 2 Trial
9个月前
Sanofi's Tolebrutinib Fails Phase 3 Trial in Primary Progressive Multiple Sclerosis
7个月前
Daratumumab Demonstrates 76% Reduction in Relapse Risk for NMOSD in Phase 3 DAWN Trial
去年
Tolebrutinib Receives FDA Breakthrough Therapy Designation for Non-Relapsing Secondary Progressive Multiple Sclerosis
去年
OCTOPUS Trial Shows Progress in Evaluating Alpha-Lipoic Acid and Metformin for Progressive MS
2年前
Tolebrutinib Shows Promise in Slowing Disability Progression in Non-Relapsing Secondary Progressive MS
去年
Sanofi's Tolebrutinib Shows Promise in Non-Relapsing Secondary Progressive MS
去年
GA Depot Shows Promise in Progressive MS with 3-Year Stability in Disability Scores
第 1 页,共 4 页
上一页
下一页